Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction

著录项

• 来源
  《European radiology》 |2017年第12期|共12页
• 作者

  Latifoltojar Arash; Hall-Craggs Margaret; Bainbridge Alan; Rabin Neil; Popat Rakesh; Rismani Ali; DSa Shirley; Dikaios Nikolaos; Sokolska Magdalena; Antonelli Michela; Ourselin Sebastien; Yong Kwee; Taylor Stuart A.; Halligan Steve; Punwani Shonit;

  展开▼
• 作者单位

  UCL Ctr Med Imaging 3rd Floor Wolfson House 4 Stephenson Way London NW1 2HE England;

  UCL Ctr Med Imaging 3rd Floor Wolfson House 4 Stephenson Way London NW1 2HE England;

  Univ Coll London Hosp Dept Med Phys &

  Bioengn London England;

  Univ Coll London Hosp Dept Haematol London England;

  Univ Coll London Hosp Dept Haematol London England;

  Univ Coll London Hosp Dept Haematol London England;

  Univ Coll London Hosp Dept Haematol London England;

  UCL Ctr Med Imaging 3rd Floor Wolfson House 4 Stephenson Way London NW1 2HE England;

  Univ Coll London Hosp Dept Med Phys &

  Bioengn London England;

  UCL Translat Imaging Grp Ctr Med Imaging Comp London England;

  UCL Translat Imaging Grp Ctr Med Imaging Comp London England;

  Univ Coll London Hosp Dept Haematol London England;

  UCL Ctr Med Imaging 3rd Floor Wolfson House 4 Stephenson Way London NW1 2HE England;

  UCL Ctr Med Imaging 3rd Floor Wolfson House 4 Stephenson Way London NW1 2HE England;

  UCL Ctr Med Imaging 3rd Floor Wolfson House 4 Stephenson Way London NW1 2HE England;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 放射医学;
• 关键词

  MRI; Whole body; Multiple myeloma; Bortezomib; Response monitoring;

  机译：MRI;全身;多发性骨髓瘤;Bortezomib;响应监测;